Real-world costs and outcomes in metastatic renal cell carcinoma patients treated with targeted therapies: a cohort study from the French health insurance database-Reference-Cited by-同舟云学术

Real-world costs and outcomes in metastatic renal cell carcinoma patients treated with targeted therapies: a cohort study from the French health insurance database

Published:2017-08-07 Issue:10 Volume:33 Page:1755-1762
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Maroun Rana¹²,Fleury Laetitia³,Nachbaur Gaelle¹,Maunoury Franck⁴,Vanhille Jean-louis³,Durand-Zaleski Isabelle²⁵

Affiliation:

1. GlaxoSmithKline, Health Outcomes Research, Marly le Roi, France;

2. INSERM, ECEVE, UMR 1123, Paris, France;

3. DRSM Ile de France, Paris, France;

4. Statesia, Le Mans, France;

5. URC-ECO, APHP, Paris, France

Funder

Association Nationale de la Recherche et de la Technologie

GlaxoSmithKline France

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2017.1360850

Reference26 articles.

1. French National Cancer Institute. Cancer INd. Les Cancers en France. Institut National du Cancer, 2015

2. Second-line treatments for the management of advanced renal cell carcinoma: systematic review and meta-analysis

3. Health Care Costs Among Renal Cancer Patients Using Pazopanib and Sunitinib

4. Disease-Specific Survival in De Novo Metastatic Renal Cell Carcinoma in the Cytokine and Targeted Therapy Era

5. Sunitinib in Metastatic Renal Cell Carcinoma: A Systematic Review of UK Real World Data

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Treatment Patterns and Effectiveness of Patients With Advanced Renal Cell Carcinoma: A Nationwide Observational Study;Clinical Genitourinary Cancer;2023-11

2. Estimated Direct Costs of Renal Cancer by Stage of Disease at Diagnosis and Phase of Its Management: A Whole-Disease Model;Clinical Genitourinary Cancer;2023-08

3. Renal cell carcinoma: the population, real world, and cost-of-illness;BMC Urology;2022-12-19

4. Management and Health Resource Use of Patients With Metastatic Renal Cell Carcinoma treated With Systemic Therapy Over 2014-2017 in France: A National Real-World Study;Clinical Genitourinary Cancer;2022-12

5. The role of diet in renal cell carcinoma incidence: an umbrella review of meta-analyses of observational studies;BMC Medicine;2022-02-03